Accessibility Menu

Merck &(FRA) 6MK

Market Cap€310.81BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1996)+1,000%
5 Year+97%
1 Year+77%
1 Month+13%
€127.34
+0.14%
+0.18Today
Merck & last closing stock price
MetricPriceDate
Last closeEUR 127.702026-09-01
Merck & stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.37%EUR 132.162026-08-25
1 month+12.63%EUR 113.382026-07-31
3 month+27.87%EUR 99.872026-06-03
Year to date+41.57%EUR 90.202025-12-30
1 year+77.36%EUR 72.002025-09-01
3 year+25.94%EUR 101.402023-09-01
5 year+97.1%EUR 64.792021-09-02
Since inception+1,000.44%EUR 11.581996-10-23

Merck & Financials at a Glance

Market Cap

€310.81BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€56.84K

Net Income (TTM)

€2.72K

EPS (TTM)

€1.07

P/E Ratio

117.31

Dividend

€2.88

Beta (Volatility)

-0.00 (Low)

Price

€127.34

Volume

45

Open

€127.60

Previous Close

€127.16

Daily Range

€127.34 - €127.60

52-Week Range

€66.40 - €134.54

Estimated Earnings Date

N/A

6MK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Merck &

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Industry

Pharmaceuticals

Employees

75,000

CEO

Robert M. Davis, MBA

6MK Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

6.95%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

0.85%

Dividend Yield

2.29%

Payout Ratio

N/A

Stock Overview

Market Cap

€310.81BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.47B

Volume

45

Avg. Volume

457

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Merck & Performance Analysis

Merck & annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 55,636,944,76234.5%
20232023-12-31EUR 55,378,906,598-0.5%
20242024-12-31EUR 59,141,672,0786.8%
20252025-12-31EUR 57,529,034,628-2.7%
Merck & annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 5.4324.9%
20232023-12-31EUR 0.13-97.6%
20242024-12-31EUR 6.234596.5%
20252025-12-31EUR 6.453.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

€14.26K

+1.0%

Gross Profit

€10.20K

+1.0%

Gross Margin

71.51%

+0.9%

Market Cap

€310.81BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€3.68

N/A

Employees

75,000

N/A

Net Income

-€1.15K

-0.3%

EBITDA

€1.99K

+0.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

€53.18K

+43.7%

Total Debt

€47.15K

+1.6%

Accounts Receivable

€10.99K

+1.1%

Inventory

€5.43K

+1.0%

Long Term Debt

€44.68K

+1.5%

Short Term Debt

€2.47K

+2.0%

Return on Assets

2.55%

+0.2%

Return on Invested Capital

15.19%

+1.1%

Free Cash Flow

€3.87K

+1.8%

Operating Cash Flow

€4.64K

+1.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
WETOWetour Robotics
$5.48-0.04%
IBITiShares Bitcoin Trust
$44.67+0.02%
INTCIntel
$89.51+0.00%

Questions About 6MK

What is the current price of Merck &?

Merck & is trading at €127.34 per share.

What is the 52-week range for Merck &?

Over the past 52 weeks, Merck & has traded between €66.40 and €134.54.

How much debt does Merck & have?

As of the most recent reporting period, Merck & reported total debt of €47.15B.

How much cash does Merck & have on hand?

Merck & reported €6.03B in cash and cash equivalents in its most recent financial results.

What is Merck &’s dividend yield?

Merck & currently has a dividend yield of 2.29%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.